The Role of Macrophage Iron Overload and Ferroptosis in Atherosclerosis

Jiedong Ma1, Hongqi Zhang2, Yufei Chen1

  • 1Department of Cardiology, Huashan Hospital, Fudan University, Shanghai 200040, China.

Biomolecules
|November 24, 2022
PubMed

Insights

Iron overload and ferroptosis in macrophages promote atherosclerosis (AS) development. Understanding iron metabolism in macrophages is key to addressing AS progression.

Area of Science:

  • Cellular biology
  • Pathophysiology
  • Biochemistry

Background:

  • Ferroptosis, a novel form of cell death driven by iron-dependent lipid peroxidation, is increasingly implicated in disease progression.
  • Atherosclerosis (AS) is a chronic inflammatory disease where macrophages play a critical role in its development and progression.
  • Iron is essential for macrophage function but its dysregulation, particularly iron overload, can lead to detrimental effects.

Purpose of the Study:

  • To elucidate the role of iron overload and ferroptosis within macrophages in the context of atherosclerosis.
  • To provide a comprehensive summary from the perspective of iron metabolism in macrophages.
  • To highlight the contribution of macrophage iron overload and ferroptosis to AS pathogenesis.

Main Methods:

  • Literature review and synthesis of existing research on ferroptosis, iron metabolism, macrophages, and atherosclerosis.
  • Analysis of the interplay between iron homeostasis, lipid peroxidation, and cell death pathways in macrophages.
  • Examination of evidence linking macrophage dysfunction to AS progression.

Main Results:

  • Iron overload in macrophages contributes significantly to the induction of ferroptosis.
  • Ferroptotic cell death in macrophages exacerbates the inflammatory processes underlying AS.
  • Dysregulated iron metabolism in macrophages is a key driver of AS development.

Conclusions:

  • Iron overload and subsequent ferroptosis in macrophages are critical factors promoting atherosclerosis.
  • Targeting iron metabolism and ferroptosis in macrophages presents a potential therapeutic strategy for AS.
  • Further research into macrophage iron dynamics is crucial for understanding and treating AS.

Related Concept Videos

Inflammation01:38

Inflammation

Overview
54.4K
Necrosis01:16

Necrosis

Necrosis is considered as an “accidental” or unexpected form of cell death that ends in cell lysis. The first noticeable mention of “necrosis” was in 1859 when Rudolf Virchow used this term to describe advanced tissue breakdown in his compilation titled “Cell Pathology”.
Morphological Manifestations of Necrosis
Necrotic cells show different types of morphological appearance depending on the type of tissue and infection. In coagulative necrosis, cells become...
4.7K
Atherosclerosis I: Introduction01:30

Atherosclerosis I: Introduction

Atherosclerosis is a progressive disorder characterized by the buildup of plaques on the arterial inner wall, causing them to narrow and harden over time. These plaques comprise lipids, calcium, blood components, carbohydrates, and fibrous tissue. The process primarily affects the intima of large and medium-sized arteries, reducing blood flow in any artery.Etiology and risk factorsThe cause of atherosclerosis is multifactorial, involving a complex interplay among endothelial injury, lipid...
35
Coronary Artery Disease II: Pathophysiology01:26

Coronary Artery Disease II: Pathophysiology

Coronary Artery Disease (CAD) originates from a series of events that impair the function of coronary arteries, the blood vessels responsible for delivering oxygen-rich blood to the heart muscle. The pathophysiology of CAD is closely linked to atherosclerosis, a chronic inflammatory and lipid-driven condition affecting the vascular endothelium.1. Endothelial DamageThe process begins with damage to the vascular endothelium, which serves as a protective barrier between the blood and the vessel...
23
The Early Endosome: Endocytosis of Transferrin01:28

The Early Endosome: Endocytosis of Transferrin

Essential proteins such as insulin or low-density lipoprotein (LDL) and micronutrients such as iron enter a eukaryotic cell through receptor-mediated endocytosis. Subsequently, the early endosomes fuse with the vesicles containing such receptor-ligand complexes and play a vital role in sorting the incoming ligands and receptors. While the ligands are either degraded inside the vesicle or released into the cytosol, their receptors are returned to the plasma membrane for further rounds of...
3.4K
Atherosclerosis III: Management01:26

Atherosclerosis III: Management

Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
19